RESEARCH PAPER · Scientific Reports · 2026
Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation
Felix Oluwasegun Ishabiyi, Haruna Isiyaku Umar, Tanmoy Duttaa, Okoyenta Celestina Onyinye, Olusola Daniel Damola, Leyla Budagova, Denekew Temesgen, Mohammed Bourhia, Ridwan Opeyemi Bello, Esmael M. Alyami, Mona Alsolami, Omar A. Almohammed
Read original paper ↗See where this research leads.
A citation map has not been saved for this paper yet.
The paper record is available below. Preparing a network uses the existing account and source-allowance controls.
Papers that cite this work
No saved citation network is available; this does not mean the paper has no citations.
